Metabolic syndrome in patients with psoriasis: A comparative study.

Background: Psoriasis patients are at increased risk of developing the metabolic syndrome (MS). Proinflammatory cytokines such as tumor necrosis factor-α, interleukin-6 that are increased in the psoriatic plaques are known to contribute to features of MS such as hypertension, dyslipidemia and insulin resistance.

Aims: (1) To establish the frequency of MS in patients with psoriasis.